Categories: Stock Market

This mid-cap stock rise 4% despite stock market crash. Do you own it?

Stock Market today: The mid-cap stock Triveni Engineering & Industries Ltd gained 4% in the intraday trades on Monday despite stock market crash. 

Triveni Engineering & Industries share price movement

Triveni Engineering & Industries share price opened at 366.55 on the BSE on Monday. The opening share price of Triveni Engineering & Industries was lower than the previous day closing price of which stood at 366.55. However the Triveni Engineering & Industries share price jumped to intraday highs of 398, despite stock market crash, when the Sensex lost more than 700 points. The rebound in Triveni Engineering & Industries meant the share price gained about 4% over the previous days close. Also the Triveni Engineering & Industries share price gained 5% over the intraday lows.

Triveni Engineering & Industries share price though had corrected significanty from 52 week high of 536 seen in December, however the Triveni Engineering & Industries share is now bounding back. The Triveni Engineering & Industries share price is now gained more than 6% in last 5 trading sessions.

Triveni Engineering & Industries developments

Triveni Engineering & Industries a few days back had announced 

Source link

nasdaqpicks.com

Recent Posts

In praise of Panzer’s, the poshest grocer’s in London

Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects her favourite stories…

3 minutes ago

Telangana emerges a key target for hackers: Seqrite report

Telangana has become a key target for hackers with 23 per cent of all malware…

8 minutes ago

Copper prices slip on tariff threat and Chinese inventories

(Recasts, adds analyst comment and changes dateline from New Delhi) LONDON, Feb 24 (Reuters) -…

9 minutes ago

Low snowfall hits Kashmir: Winter sports cancelled, business suffers and water crisis looms

Kashmir has been caught in the throes of a protracted dry spell with the region experiencing an…

16 minutes ago

German healthcare boss says his business is better bet than Big Pharma

Stay informed with free updatesSimply sign up to the Pharmaceuticals sector myFT Digest -- delivered…

19 minutes ago

Miltenyi Biotec sets up cell and gene therapy CoE excellence in Hyderabad

Germany-based Miltenyi Biotec, a provider of cell and gene therapy (CGT) solutions, opened a dedicated cell…

23 minutes ago